This article explains how regulators assess the Pharmacovigilance System Master File during inspections, where governance gaps create audit findings, and why clear accountability, traceability, and inspection readiness determine long-term regulatory confidence.

This article explains how PSURs support regulatory assessment through structured benefit–risk evaluation, safety data integration, and inspection readiness, helping organizations maintain consistent safety reasoning and meet evolving regulatory expectations across post-marketing reporting cycles.